What is LOPJLB’s current signal on ALEC?

LOPJLB’s latest quantitative signal on Alector, Inc. (ALEC) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is ALEC in?

Alector, Inc. (ALEC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Alector, Inc. (ALEC) do?

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are …

Where is Alector, Inc. based / listed?

Alector, Inc. is based in US, listed on NASDAQ.

Alector, Inc. (ALEC)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.08+2.97%Close

SELLRECOVERY · day 3

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 0
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-58.1%

GROSS

-361

-915

NET

-850

[VALUATION]

P/E TTM-1.65

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B-20.19

P/FCF-

EV/EBITDA-1.61

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO5.26

ND/EBITDA-

BETA0.62

Alector, Inc. (ALEC)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news